148 related articles for article (PubMed ID: 6442920)
1. A study of some pharmacological actions of carbamazepine and sodium valproate.
Mansuri SM; Raval JD; Girdhar AO; Gandhi TP
Indian J Physiol Pharmacol; 1984; 28(4):315-8. PubMed ID: 6442920
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part II: Central and peripheral nervous systems.
Hirohashi M; Takasuna K; Kasai Y; Usui C; Kojima H
Arzneimittelforschung; 1991 Jan; 41(1):19-24. PubMed ID: 1675569
[TBL] [Abstract][Full Text] [Related]
3. Some pharmacological actions of cyclizine, chlorcyclizine and homchlorcyclizine.
Pendse VK; Madan BR
Indian J Physiol Pharmacol; 1969 Jan; 13(1):31-6. PubMed ID: 4390896
[No Abstract] [Full Text] [Related]
4. Pharmacology of Acorus calamus L.
Panchal GM; Venkatakrishna-Bhatt H; Doctor RB; Vajpayee S
Indian J Exp Biol; 1989 Jun; 27(6):561-7. PubMed ID: 2583746
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological studies on oxatomide. (5). Effect on the central and peripheral nervous systems].
Ohmori K; Ishii H; Shuto K; Nakamizo N
Nihon Yakurigaku Zasshi; 1983 Mar; 81(3):245-66. PubMed ID: 6134657
[TBL] [Abstract][Full Text] [Related]
6. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
Lenox RH; McNamara RK; Watterson JM; Watson DG
J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
[TBL] [Abstract][Full Text] [Related]
7. [To the pharmacology of the alkaloid eburnamonine].
Trutneva EA; Berezhinskaia VV
Farmakol Toksikol; 1966; 29(2):171-5. PubMed ID: 6000339
[No Abstract] [Full Text] [Related]
8. Carbamazepine suppression of post-tetanic potentiation at the neuromuscular junction.
Hershkowitz N; Dretchen KL; Raines A
J Pharmacol Exp Ther; 1978 Dec; 207(3):810-6. PubMed ID: 731433
[TBL] [Abstract][Full Text] [Related]
9. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
[TBL] [Abstract][Full Text] [Related]
10. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H
Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the pharmacologic effects of morphine and N-methyl morphine.
Foster RS; Jenden DJ; Lomax P
J Pharmacol Exp Ther; 1967 Jul; 157(1):185-95. PubMed ID: 6029484
[No Abstract] [Full Text] [Related]
12. Characterization of the neuromuscular blocking property of isococculidine.
Kar K; Mukherjee KC; Dhawan BN
Indian J Exp Biol; 1977 Jul; 15(7):547-51. PubMed ID: 598896
[No Abstract] [Full Text] [Related]
13. Some effects of piperazine citrate on skeletal muscle and central nervous system.
Onuaguluchi G; Mezue WC
Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):104-16. PubMed ID: 3446036
[TBL] [Abstract][Full Text] [Related]
14. General pharmacology of recombinant human basic fibroblast growth factor.
Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
[TBL] [Abstract][Full Text] [Related]
15. Skeletal neuromuscular and smooth muscle effects of whole venom of the green mamba, Dendroaspis angusticeps - I.
Wangai J; Thairu K; Telang BV
Indian J Physiol Pharmacol; 1981; 25(2):176-9. PubMed ID: 7287140
[TBL] [Abstract][Full Text] [Related]
16. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
17. The effects of equinatoxin II on respiration--possible mechanism of the toxin lethality.
Bunc M; Frangez R; Rozman J; Suput D
Pflugers Arch; 2000; 439(3 Suppl):R129-30. PubMed ID: 10653165
[TBL] [Abstract][Full Text] [Related]
18. Influence of sodium valproate and carbamazepine on GSH levels in rat cerebral cortex.
Attaguile G; Caruso A; Cutuli VM; Di Giacomo C; Russo A; De Bernardis E; Amico-Roxas M
Drugs Exp Clin Res; 1992; 18(11-12):465-7. PubMed ID: 1308471
[TBL] [Abstract][Full Text] [Related]
19. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 2nd communication: Effects on central nervous and sensory systems and on the other functions.
Matsuno Y; Hori H; Oka M; Nakamura H; Ito T; Kadokawa T
Arzneimittelforschung; 1986; 36(1):62-8. PubMed ID: 3513778
[TBL] [Abstract][Full Text] [Related]
20. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
